Pharmaceuticals Research This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 33.

Record crowd honors 100 Women of Influence
This was year five for our Women of Influence Business Journal event and the energy in the room was incredible. We had a record number of attendees, 970, and the faces of the 100 honorees said it all: They were excited and proud to have been chosen for the Class of 2012. Tomi Ryba, the CEO of El Camino Hospital (also an honoree) set the stage for the night. She stood at the podium, looked out on the crowd of mostly women and said, “If we all worked in the same company, imagine what we could all...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2012 Category: Pharmaceuticals Authors: Moryt Milo Source Type: research

Feds raid Southwest Houston clinic for alleged fraud
Federal agents raided the Westbury Community Hospital Outpatient facility, examining documents for suspected Medicare fraud. KPRC Houston reports that the clinic treats schizophrenic patients during the day who are then taken home at night. On April 26, agents from the Federal Bureau of Investigation, the Internal Revenue Service and the Houston Police Major Offenders Division questioned clinic's employees and took away records to examine. The Westbury clinic does collect Medicare money for its...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2012 Category: Pharmaceuticals Source Type: research

Tenet Healthcare repurchases $299 million in preferred stock
Tenet Healthcare, which owns Saint Louis University Hospital and Des Peres Hospital, has repurchased $299 million in preferred stock, the Dallas Business Journal reports. The Dallas-based hospital company said the move shows the confidence the company has in the value of its stock. Tenet announced preliminary first-quarter results that include net operating revenue of $2.35 billion, up 2.2 percent from the same quarter last year.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2012 Category: Pharmaceuticals Source Type: research

Business Journal announces Women of Influence winners
Helen Johnson-Leipold, chairwoman of Johnson Financial Group, and Kristine Seymour, president of Humana Inc. Wisconsin, highlight the list of the winners of The Business Journal’s 2012 Women of Influence awards.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2012 Category: Pharmaceuticals Source Type: research

Survey shows which doctors earn most and least
The latest annual survey of physician pay from Medscape/WebMD shows that income overall has declined since 2010, and that frustration is growing among doctors in every specialty as they brace for changes in how health care is implemented. The survey also shows that most doctors would choose the career again, and which fields pay the most and least. A USA Today analysis of the survey of 24,000 U.S. physicians in 25 specialties, shows that among the highest-paid doctors are: radiologists: $315,000,...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2012 Category: Pharmaceuticals Source Type: research

UB streamlines its advanced degree program for nurses
The School of Nursing at the University at Buffalo is simplifying the process for registered nurses to obtain advanced degrees in nursing education. UB’s doctor of nursing practice degree was introduced last summer for those with a bachelor’s degree in nursing. In the fall, it was offered to advanced practice nurses with a master’s degree in nursing. The school has now announced it is making the following changes to its program: • Registered nurses with a master’s degree may pursue the...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2012 Category: Pharmaceuticals Authors: Allissa Kline Source Type: research

Top of the List: Independent senior housing communities
Here is a list of the seven top Capital Region independent senior housing communities ranked by the current number of residents. To see the Top 7, click on the slideshow on the right. Our full list of the Top 24 independent senior housing communities, including types of units, rate structures and rate ranges, is available only to subscribers to The Business Review in print or our e-dition. Every week we bring you lists like this in our paper. Click here to subscribe to the print edition. Would...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2012 Category: Pharmaceuticals Authors: Neil Springer Source Type: research

Grifols shifting 100 Raleigh jobs to Texas
Fresh off its takeover of Talecris Biotherapeutics, Barcelona-based Grifols is closing a plasma testing facility in Raleigh, resulting in the loss of about 100 local jobs. The test lab will be phased out through December, company spokesperson Becky Levine says.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2012 Category: Pharmaceuticals Source Type: research

Hundreds of jobs in Baltimore health systems
There are hundreds of jobs waiting in our region’s health care systems. In our List survey, hospitals and health systems responded that they are especially eager to hire more good nurses, but that’s far from the only opportunity. Below are the positions each mentioned they are looking to fill, and many more are listed on each system’s websites: Anne Arundel Health System Inc. is looking for RNs, MDs and ancillary staff. Bon Secours Baltimore Health System is especially in need of more emergency...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2012 Category: Pharmaceuticals Authors: Carolyn Proctor Source Type: research

Top of the List: Baltimore's busiest hospitals
Each week we give you a countdown of the top five to 10 companies or organizations from one of our Lists publishing in our Friday paper. This week it’s the “Busiest hospitals in the Baltimore area.” The List is ranked by number of cases (including all admissions plus babies born) at each hospital in 2011, from data collected by the Maryland Health Services Cost Review Commission. Here they are, counting back from No. 5: 5. MedStar Franklin Square Hospital Center Address: 9000 Franklin Square...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2012 Category: Pharmaceuticals Authors: Carolyn Proctor Source Type: research

HealthSouth reports revenue increase in 1Q
HealthSouth Corp. (NYSE: HLS) reported strong first quarter results today with net operating revenues climbing more than 6 percent to $538.6 million for the quarter ending March 31. Overall, patient discharges were up 6 percent and net patient revenue per discharge was up 2.2 percent – not accounting for leap year, which added an extra day to the quarter. Meanwhile, net income attributable to common shareholders was down 49 percent at $37.3 million, due largely to a tax settlement that inflated...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Evan Belanger Source Type: research

Better news on apps at Kaiser Permanente, but still no iPhone version
Kaiser Permanente, which hyped its mobile device app’s progress back in January before it had a lot to crow about, has some real numbers now. To wit, the Oakland-based health care giant says 94,367 of its Android apps have been downloaded — up from just 2,100 in late January. Meanwhile, 74,295 locator apps, used by Kaiser members to locate their nearest Kaiser hospital or clinic, have found their way onto mobile phones. Altogether, Kaiser officials told the San Francisco Business Times April...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Chris Rauber Source Type: research

Transcept seeks $37M from stock offering
Transcept Pharmaceuticals Inc. would use some of the $37.6 million it hopes to net from a public stock offering to sell its FDA-approved middle-of-the-night sleep drug and to move forward with a drug for obsessive compulsive disorder. Transcept priced the offering of 4.5 million shares at $9 per share. The Richmond company (NASDAQ: TSPT) said Thursday that it will use the cash for development of TO-2061, its Phase II drug for obsessive compulsive disorder, working capital and capital expenditures. It...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Ron Leuty Source Type: research

Onyx multiple myeloma drug to face FDA committee June 20
Onyx Pharmaceuticals Inc.’s cancer drug carfilzomib must face a Food and Drug Administration advisory committee, the company said Thursday. South San Francisco-based Onyx (NASDAQ: ONXX) said the FDA’s Oncologic Drugs Advisory Committee will meet June 20 to discuss carfilzomib, a drug aimed at patients with relapsed or refractory multiple myeloma who have received at least two prior therapies. The FDA, which is not required to follow the committee’s recommendation, is scheduled to make its...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Ron Leuty Source Type: research

Adventist HealthCare lays off "fewer than 100"
Citing expected action by Maryland health regulators to decrease hospital rates and other issues, Adventist HealthCare is eliminating "fewer than 100" jobs in layoffs announced to employees this week. Rockville-based Adventist, which runs two hospitals in Montgomery County and a network of affiliated services, also said health care reform and general economic troubles are forcing it to reduce costs. "Actions we are taking include making sure our work force accurately reflects this new economic...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Ben Fischer Source Type: research

Centene CEO Neidorff pledges $5 million to Trinity University
Michael Neidorff and his wife, Noémi, and Centene Corp. have pledged to donate $5 million toward the ongoing development of the Center for the Sciences and Innovation at Trinity University in San Antonio, the San Antonio Business Journal reports. The university broke ground on the 280,000-square-foot, $127 million project in May 2010. Neidorff, chairman and CEO of St. Louis-based Centene, is a 1965 graduate of Trinity and a member of the school’s board of trustees. Centene (NYSE: CNC), a managed...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Greta Weiderman Source Type: research

Adventist takes over management of Hospice of the Comforter
Adventist Health System will have full management authority over Hospice of the Comforter effective May 1 for the next three years, the hospice announced April 26. Adventist will provide on-site senior management of daily operations. Hospice of the Comforter’s board of directors will remain in an oversight position. The hospice is the subject of a whistle-blower lawsuit filed by former executive Douglas Stone, who claimed he was one of two vice presidents forced out after warning hospice officials...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Abraham Aboraya Source Type: research

Health care community urged to “keep an open mind” about change
In the midst of election-year showcasing regarding issues of taxation, health care and other political flashpoints, an intimate group of local health care executives gathered at Fleming’s Prime Steakhouse today to hear Deborah Holzmark deliver a presentation on one of Memphis’ most robust industries. Holzmark, director of health care consulting for Dixon Hughes Goodman LLP, talked about the nuts and bolts of accountable care models and how to best prepare to deal with the changing environment...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Cole Epley Source Type: research

Cerner rides shift to electronic health records to higher revenue, profits
Cerner Corp. reported continued sizable increases in profits and revenue in the first quarter as hospitals and physician offices continue moving from paper patient records to computer databases. The North Kansas City-based company (Nasdaq: CERN) on Thursday reported earning $88.7 million, or 51 cents a share, during the three months ending March 31. By comparison, Cerner earned $64.6 million, or 37 cents a share, during the same period a year ago. The results have been adjusted to reflect a two-for-one...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: David Twiddy Source Type: research

As Supernus Pharmaceuticals IPO awaits, pundits deem it risky
Supernus Pharmaceuticals Inc.'s initial public offering hasn’t happened yet. We thought it would be Wednesday. But here we are, a day later, and it hasn’t even priced. As we wait for Supernus to list its stock on the Nasdaq in what would be the region’s first biotech IPO since Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP) in 2007, some observers have been taking some potshots at the offering this week. Here’s IPOdesktop President Francis Gaskins: “Problem is that they lost on an operating...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Bill Flook Source Type: research

AstraZeneca seeks to refill dry pipeline with gout drug
UK pharma giant splashes out $1.26 billion on US gout specialist Ardea Biosciences
Source: Chemistry World | Latest News - April 26, 2012 Category: Chemistry Source Type: research

PHC4: Readmissions cost $498 million
Heart failure, mental health problems and abnormal heartbeat were the three top reasons for readmission to a hospital within a month of discharge in Pennsylvania in 2010, according to a new report. Harrisburg-based Pennsylvania Health Care Cost Containment Council found that readmissions cost Medicare nearly $500 million during 2009, the most recent year data were available. Medicare fee-for-service paid $498 million for repeat stays within a month of discharge, accounting for 36.8 percent of all...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Kris B. Mamula Source Type: research

Senate approves $24 billion Missouri budget
The Missouri Senate on Wednesday signed off on a $24 billion budget that gives a raise to state workers and avoids cuts to a blind health care program, KSKD reports. The budget will provide a 2 percent raise for tens of thousands of state workers who earn up to $45,000 a year, and the senators voted to continue funding a program that provides free health coverage to 2,800 blind residents. The Senate and House must pass a final budget by May 11.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Source Type: research

Senate votes to help Postal Service
The U.S. Postal Service might get financial relief -- and potentially the ability to drop Saturday delivery -- in a bill passed Wednesday night by the Senate. The New York Times reported on the bill that doesn't seem to make anyone happy, either Republicans concerned about the national debt, postal unions or the Postal Service itself. The Postal Service would be allowed to restructure its prepaid health benefits that has cost it $20 billion since 2007 and as many as 100,000 postal employees would...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Source Type: research

AstraZeneca CEO stepping down
AstraZeneca CEO David Brennan will leave the pharmaceutical giant (NYSE:AZN), which has its U.S. headquarters in Wilmington, Del., in June, the Philadelphia Inquirer reports. "The company has struggled lately as it tried to replace revenue from some of its blockbuster drugs that were facing generic competition because their patents are expiring," the Inquirer notes.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Source Type: research

The List: Top 10 corporate philanthropists
Some corporations with large Triangle presences give millions to nonprofit causes throughout the area. These companies include publicly held firms such as IBM, Cisco Systems and Biogen Idec as well as large private concerns like Investors Management Corp. and Blue Cross and Blue Shield of North Carolina. But just which ones are the largest in terms of local giving? Click below to find out.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Source Type: research

Tampa Bay area walkers halfway to moon in health quest
Walking 238,857 miles seemed like a huge undertaking, when One Bay: Healthy Communities unveiled a "Walk to the Moon" challenge. But only three weeks into the challenge, walkers from 77 local companies are 70 percent of the way there, walking a total of 171,759 miles. With four weeks to go before the challenge ends May 23, Steve Mason, chair of One Bay: Healthy Communities, thinks there's plenty of time for them to walk back to earth as well. Nearly 25 percent of the miles walked so far, or 41,549...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Margie Manning Source Type: research

University of South Florida inventors up for $50K prize
Two student inventors from the University of South Florida are finalists for a $50,000 Cade Museum Prize. Their project, eCath, is an electronic catheter stethoscope that will let doctors listen to the inside of the body with non-invasive sensors, according to the Gainesville Sun. There are three other inventors in the running for the prize out of more than 120 inventors and entrepreneurs who applied across the state. So far, USF's Phil Hipol and Stuart Hart have survived three rounds of judging...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Source Type: research

Medical device company raises $625K
Raleigh-based medical device company Corinthian Ophthalmic Inc. has raised $625,000 in equity, according to securities filings. But the company still has a long way to go to reach its goal of raising $4 million by the end of May. “We’re looking to get this closed as soon as possible,” says President Skip Ballou. The money will be used for a new device that Ballou hopes could replace the eyedropper.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Lauren K. Ohnesorge Source Type: research

Taunton State Hospital backers lose this round
The state House of Representatives has failed to support a budget amendment that would have kept open the Taunton State Hospital, which as the Sun Chronicle reports is an early blow to advocates of the effort to maintain the 169-bed facility. Taunton State Hospital is one of six state-run inpatient mental health facilities, and Gov. Deval Patrick announced its planned closure earlier this year. the announcement has been met with widespread disapproval, given plans to ship services from Taunton to...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Source Type: research

Digest
In conclusion, trial‐based evidence suggests no clear and convincing advantage for cognitive behavioural therapy over other – and sometime much less sophisticated – therapies for people with schizophrenia.Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD008712. DOI: 10.1002/14651858.CD008712.pub2
Source: Progress in Neurology and Psychiatry - April 26, 2012 Category: Neurology Tags: Digest Source Type: research

California Health Benefit Exchange delays IT contract award
Vendors interested in a plum contract with the California Health Benefit Exchange to build an information technology system for the program will have to wait a little longer to find out who got the business. The announcement, expected Tuesday, has been delayed. The award is still under negotiation, David Panush, government relations director for the exchange, said Wednesday. The contract is valued at $27 million through August and much more — possibly hundreds of millions of dollars — after...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2012 Category: Pharmaceuticals Authors: Kathy Robertson Source Type: research

Synergetics’ COO Kurt Gampp Jr. resigns
Officials from Synergetics USA Inc. said today that Kurt Gampp Jr. plans to resign as executive vice president and chief operating officer, effective May 4. Gampp, who worked at Synergetics for 21 years since its founding in 1991, is leaving to "pursue another entrepreneurial venture," according to a statement by the company. O’Fallon, Mo.-based Synergetics USA (NASDAQ: SURG), led by President and CEO David Hable, is a medical device company that designs, manufactures and markets innovative microsurgical...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 25, 2012 Category: Pharmaceuticals Authors: Greta Weiderman Source Type: research

Top six UnitedHealth Group executives average $10M a year in pay, including interim Best Buy CEO Mikan
Tracking the pay of Minnesota’s business leaders Stephen Hemsley CEO UnitedHealth Group Inc. (NYSE: UNH) Headquarters: MinnetonkaBusiness: Health insurance News The top six executives at UnitedHealth Group were paid $62.7 million combined in 2011 — an average of more than $10 million per person. Included was G. Mike Mikan, who left UnitedHealth Group at the beginning of July. He was paid $9.2 million for his six months of work in 2011. Mikan resurfaced earlier this month, taking over as...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 25, 2012 Category: Pharmaceuticals Authors: Ed Stych Source Type: research

Seattle has big impact on global fight against malaria
It’s World Malaria Day, and Seattle research organizations and foundations are doing their part to spread awareness and invest in research. Seattle is one of only four places in the world where controlled human malaria infections to test vaccines can be done, said Ken Stuart, president emeritus and founder of Seattle Biomedical Research Institute. One of the reasons is that controlled human malaria tests require a facility capable of producing mosquitoes needed for the research, such as the insectary...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 25, 2012 Category: Pharmaceuticals Authors: Valerie Bauman Source Type: research

VA to expand mental health staff in southern region
The U.S. Department of Veterans Affairs plans to add 202 clinicians and 39 support personnel for mental health operations in its South Central VA Health Care Network, which includes VA facilities in Texas, Arkansas, Oklahoma, Louisiana and Mississippi. The additions are part of the approximately 1,600 mental health clinicians and nearly 300 support staff VA plans to add nationwide. VA expects to hire most of the new clinicians and staff within six months. The hardest-to-fill positions should be...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 25, 2012 Category: Pharmaceuticals Authors: Olivia Pulsinelli Source Type: research

Merritt Hawkins helps design hospital board materials
Irving-based physician staffing firms Merritt Hawkins and Staff Care, companies of AMN Healthcare, will partner with Texas Healthcare Trustees to bring educational tools to Texas hospital board members, officials with both companies have announced. Merritt Hawkins and Staff Care were selected by Austin-based nonprofit THT to provide hospital trustees with resources pertaining to physician/hospital relations, physician recruiting, compensation, retention, temporary staffing, and other workforce and...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 25, 2012 Category: Pharmaceuticals Authors: Bill Hethcock Source Type: research

Report: Bayer closing in on takeover of drug partner Onyx
Drug developer Onyx Pharmaceuticals Inc.’s stock closed up 9 percent on rumors that longtime partner Bayer AG will soon close a deal to buy the South San Francisco biotech company. Bayer is zeroing in on a large acquisition, Reuters reported Wednesday. One source told the news agency that Marjin Dekkers, CEO of the German drug maker, is “keen to do something and it could happen within the next couple of days.” Folks who watch for mergers and acquisitions like Kremlinologists during the Cold...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 25, 2012 Category: Pharmaceuticals Authors: Ron Leuty Source Type: research

McConnell: Targacept downsizing not a concern
Dr. John McConnell, CEO of Wake Forest Baptist Medical Center, said he does not believe the downsizing at anchor tenant Targacept Inc. will have a lasting negative impact on the Piedmont Triad Research Park. Targacept (NASDAQ: TRGT) announced Wednesday morning that it will lay off 65 people, or about 46 percent of its workforce, following the failure of an antidepressant drug candidate in Phase 3 clinical trials. Targacept is the largest biotech organization in the research park that's not directly...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 25, 2012 Category: Pharmaceuticals Authors: Matt Evans Source Type: research

Ohio Third Frontier recommends $1M in funding for tech projects
Ohio Third Frontier Commission recommended nearly $1 million in funding for 13 technology projects across the state, including one in Cincinnati. The funding would come through the Ohio Third Frontier Technology Validation and Start-up Fund, which promotes commercialization of Ohio technologies developed by the state’s institutions of higher education. “Ohio’s institutions of higher education are on the forefront of research that can provide a sizable economic benefit to Ohio companies,”...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 25, 2012 Category: Pharmaceuticals Source Type: research

Judge denies bid to stop Express Scripts, Medco merger
A judge in Pittsburgh today denied an injunction by the National Association of Chain Drug Stores, the National Community Pharmacists Association and independent pharmacies to undo the $29.1 billion merger of Express Scripts Inc. and Medco. U.S. District Judge Cathy Bissoon denied the motion, stating the pharmacy groups did not provide sufficient evidence to temporary halt the deal. The trade groups sued Express Scripts and Medco on March 29, claiming the merger would violate antitrust laws by reducing...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 25, 2012 Category: Pharmaceuticals Authors: Matthew Hibbard Source Type: research

Cornerstone to launch joint venture for health care consulting
Cornerstone Health Care and Holston Medical Group of Kingsport, Tenn., have formed a joint venture to offer consulting services to physician groups looking to transition from a "fee for service" business model to a "fee for value" structure. The venture comes as Cornerstone is undertaking just such a transition, as announced last year by the High Point-based physician group. Cornerstone plans to hire more than 135 new workers and invest more than $25 million as it shifts its business and care models. "Making...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 25, 2012 Category: Pharmaceuticals Authors: Owen Covington Source Type: research

Inhibition of acetyl-CoA carboxylase 2 enhances skeletal muscle fatty acid oxidation and improves whole-body glucose homeostasis in db/db mice
Conclusions/interpretation In conclusion, the ACC2-selective inhibitor (S)-9c revealed glucose-lowering effects in a mouse model of diabetes mellitus. Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-012-2554-9Authors S. Glund, CardioMetabolic Diseases Research, Boehringer Ingelheim Pharma GmbH& Co. KG, 88397 Biberach an der Riss, GermanyC. Schoelch, CardioMetabolic Diseases Research, Boehringer Ingelheim Pharma GmbH& Co. KG, 88397 Biberach an der Riss, GermanyL. Thomas, CardioMetabolic Diseases Research, Boehringer Ingelheim Pharma GmbH& Co. KG, 88397 Biberach an der Riss, Ger...
Source: Diabetologia - April 25, 2012 Category: Endocrinology Tags: Diabetologia Source Type: research

Carolina Liquid Chemistries launching new blood analyzer
Carolina Liquid Chemistries is launching the first product from its new headquarters located at the Piedmont Triad Research Park's Wake Forest Biotech Place building. The device, called the CLC 720, is a chemistry analyzer that can process 100 different blood chemistry tests for such things as glucose or cholesterol levels or drug abuse. The system received FDA clearance in March and is the second chemistry analyzer that Carolina Liquid Chemistries has developed in the research park. In a press...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 24, 2012 Category: Pharmaceuticals Authors: Matt Evans Source Type: research

Thomasville Medical Center tops in charity care, newspaper finds
Thomasville Medical Center, part of Winston-Salem-based Novant Health, Inc., spends a larger portion of its budget on charity care than any other nonprofit hospital in the state, according to research by the Charlotte Observer and the News & Observer of Raleigh. The sister newspapers are in the midst of a five-day series looking at the profitability of nonprofit hospitals in North Carolina, and singled out the Thomasville hospital for its commitment to charity care, which is when a hospital...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 23, 2012 Category: Pharmaceuticals Authors: Owen Covington Source Type: research

Ironwood faces 3-month FDA delay for potential IBS drug linaclotide
Ironwood Pharmaceuticals Inc. (Nasdaq: IRWD) and its partner Forest Laboratories Inc. (NYSE: FRX) have announced the U.S. Food and Drug Administration will delay its approval decision for the companies’ potential drug for irritable bowel syndrome (IBS), called linaclotide. The delay is due to the agency’s request for an additional analysis of existing clinical data, the companies said. The FDA has not requested a new clinical trial. The drug candidate was submitted to the FDA in August 2011...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 23, 2012 Category: Pharmaceuticals Authors: Julie M. Donnelly Source Type: research

Supernus Pharmaceuticals readies D.C. region’s first biotech IPO since 2007
Supernus Pharmaceuticals Inc. is slated to go public this week, more than a year after first filing paperwork to list its stock on the Nasdaq. The Rockville biotech is expected to start trading on Wednesday. When we wrote about the planned public offering two days before Christmas 2010, we noted that Supernus would be the region’s first biotech IPO since 2007. That’s still true today. The vast chronological gap between Supernus' expected IPO this week and Sucampo Pharmaceuticals’ IPO five...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 23, 2012 Category: Pharmaceuticals Authors: Bill Flook Source Type: research

The 99% Spring anti-corporate protesters to disrupt shareholder meetings of Amazon, others
Corporate America, get ready: The folks who brought you Occupy Wall Street last year may confront you at your next shareholder meeting. Activists with The 99% Spring coalition already have disrupted shareholder meetings this year at EQT Corp. (EQT), Carnival Cruise Lines (CCL) and BNY Mellon (BK). Now they’ve announced a full schedule of “non-violent direct action” at shareholder meetings, starting next week with Wells Fargo and General Electric and also including Seattle-based Amazon.com...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 23, 2012 Category: Pharmaceuticals Authors: Kent Hoover Source Type: research

St. Jude researchers to study protein’s ability to suppress tumors
St. Jude Children’s Research Hospital scientists have found a protein in humans that may help suppress tumors. In a paper published in the April 22 online edition of scientific journal Nature Neuroscience, researchers at St. Jude in Memphis found the protein TopBP1 demonstrates that it guards early brain cells from incurring DNA damage. Such damage could forecast later problems, including cancer. Within the brain study, when the scientists “selectively knocked out TopBP1 in mice, the amount...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 23, 2012 Category: Pharmaceuticals Source Type: research

Clarence low-nicotine tobacco co. reports loss
22nd Century Group Inc., a Clarence specialty tobacco products manufacturer, reported annual revenues of $1 million for 2011, but the company continues to operate at a loss. According to annual reports filed last week with the Securities and Exchange Commission, the company (OTCBB: XXII) had a net loss $1.35 million, for the year ended Dec. 31, 2011. That compares to losses the previous year of $1.42 million. The company’s stock closed Friday at $0.68 per share, down from $1.25 per share a year...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 23, 2012 Category: Pharmaceuticals Authors: Tracey Drury Source Type: research